There are a number of applications for Erchonia Corporation’s groundbreaking laser devices. Based on Erchonia’s Level one clinical study results in 2002, the FDA found it necessary to create a new regulatory category of medical devices: NHN Biostimulation lasers.
Chronic Low Back Pain
About 80 percent of adults experience low back pain at some point in their lifetimes. Of those, about 60% are treated with opioids, despite the opioid epidemic and minimum effectiveness (30%). Erchonia’s FX 635 laser showed a 72% success rate in their clinical trial, which received FDA market clearance in May 2018. The FX 635 treatment of chronic low back pain is groundbreaking in the pain management community and give patients a safer, more effective treatment option that will get them back on their feet in no time.
Erchonia lasers are proven to target and release fat in areas that are difficult to target with regular diet and exercise. The Zerona laser is proven to target these difficult areas to open a transitory pore in the cell membrane to release fat. The Erchonia EML laser approved as an addition to traditional liposuction surgery. It is the first and only low-level laser to be given FDA market clearance for use immediately before liposuction. The painless laser treatment is applied prior to liposuction and liquefies the fat. This makes for a much easier removal of fat, and results in less post-op pain and bruising as well as a much shorter recovery time.
Neck and Shoulder Pain
Erchonia low level lasers are proven to be effective in reducing and eliminating chronic pain in the neck & shoulders. Many patients find that this solution is a much more effective and immediate alternative to traditional pain medications. The Erchonia lasers have been proven through rigorous clinical trials in which subjects had to refrain from any therapies, beside the laser. However in practice doctors are combining with forms of chiropractors and therapy, to help patients lead a normal, active, and healthy life without debilitating pain.
Currently, there are many acne treatments available in the form of pills, lotions, tonics, chemicals, and more, but Erchonia has developed a new solution with the EVRL LASER. This FDA market cleared laser targets the actual type of bacteria that is responsible for causing acne, rather than targeting the skin. This treatment does not lead to irritated skin cells because it attacks the cause of acne at the root. Rather than spending many months or years on powerful antibiotics, creams, and more, patients can now attach their acne with painless low-level laser treatments. Cold lasers are currently undergoing studies for new indications for use. Though it is a relatively new field of medicine, Erchonia’s commitment to low-level laser treatment has made great advancements for laser technology. The future of medical lasers is certainly bright.
Approximately two-thirds of U.S. adults are either overweight or obese and one-third are clinically obese. The Emerald laser is the only non-invasive device FDA Cleared to treat up to 40BMI. Published clinical data demonstrated over 70% of study individuals obtained 3 inch or greater circumference reduction following 6 weeks. During this time the individuals agreed to maintain their regular diet and exercise routine for the duration of the study, however healthy lifestyle changes are recommend.
Plantar fasciitis is the most common cause of heel pain in adults, affecting 1 million persons each year in the United States. Treatment ranges from rest to surgical intervention. Erchonia’s LLLT has received FDA clearance as an adjunct treatment for Plantar Fasciitis due to the treatment’s safe and efficacious nature. In a 3 week study, on average individuals experienced a 50% reduction in pain, with pain reduction either improving or sustaining up to 12 months post treatment
Onychomycosis is an infection of the finger or toenails causing the unsightly appearance of nails. Current therapies include oral and topical medications, however medications do come with a risk of possible side effects. Another treatment option is Erchonia’s LLLT which received FDA Clearance in 2016. The treatment involves only 4 non-thermal laser sessions with no known side effects.